Introduction
The notion that inherited genetic factors are involved in the development of haematological malignancies such as chronic lymphocytic leukaemia (CLL) is generally viewed as a new concept. 1 This is, however, not the case. In 1947, Videbaek published a seminal work on leukaemia, 2 in which he proposed that subsets of most common haematological malignancies including CLL have a familial basis. This conclusion followed from a systematic observational study of the pedigrees of 209 leukaemia patients. Reports of the familial aggregation of cancer in single families have in the past been generally viewed with scepticism, being dismissed as a consequence of ascertainment bias. However, this is a statistical fallacy as large pedigrees with multiple affected family members can provide some of the most convincing evidence for an inherited predisposition.
3 This is eminently illustrated by 'Family G' originally reported by Warthin in 1913, which was extended by Lynch and Krush in 1971 4 and directly led to the recognition of the syndrome of hereditary nonpolyposis colorectal cancer (HNPCC). Aside from providing strong evidence for inherited genetic factors in the aetiology of a disease, the ascertainment of multiple-case families is central to the identification of cancer genes by positional cloning.
In 1999, we formed a consortium to ascertain and collect families with multiple cases of CLL in order to identify a disease locus through genetic linkage analysis. During the course of developing this initiative, we explored the possibility that we might be able to extend families previously reported in the literature and through hand searching published case-reports, we became aware of the work of Videbaek (1947) . 2 Of the 209 families detailed by Videbaek, 2 39 were reported to have two or more individuals affected with CLL. To determine the viability of pursuing descendants of these families for linkage analysis, we selected the largest family, Pedigree 14 for detailed follow-up. Here, we report the complete tracing of 222 descendants of the original 57 family members of this pedigree, which provides strong evidence for inherited susceptibility to CLL.
Materials and methods

Videbaek
2 detailed the patient record number, hospital in Copenhagen and the year of admission of each of the four cases of leukaemia (two cases of CLL, one case of CML and one case of eosinophilic leukaemia) within Pedigree 14. Since 1947 all data on the Videbaek families data have been stored in the Royal Danish Archives and The Provincial Archives of Sealand. These agencies granted us permission to obtain the names, the dates and the places of birth of members of Pedigree 14. The Civil Registration System of Denmark and The National Collection of Midwife-Books were then used to identify all additional members of the family and assign relationships. For family members alive on the 1st of April 1968, individuals' unique 10-digit personal identification numbers were obtained from The Danish Central Population Register. Family members were then linked to The National Mortality Files and The Central Population Register for information on vital status and migration as of 1st of August 2004. Information on cancer occurrence in family members was obtained by record linkage to The Danish Cancer Registry, which collects diagnostic details on all individuals with cancer in Denmark. 5 The period of follow-up for cancer began at the date of birth or 1 January 1943, whichever occurred later, and ended at the date of death, date of emigration or 31 December 2002, whichever occurred first. Expected numbers of cancers were calculated using age-, sexand calendar-specific incidence rates for Denmark. The 95% confidence intervals (CIs) of standardized incidence ratios (SIRs) were estimated assuming a Poisson model of the observed cancers. 6 A P-value of 0.05 was considered statistically significant. All P-values are two-sided. In situ and precancers were not included in the analysis. Statistical analyses were performed using software programs SAS (SAS Institute Inc., Cary NC, USA) and STATA Version 7 (Stata Corporation
com).
Results and discussion Figure 1 shows Pedigree 14 as reported by Videbaek in 1947. Four of the original 57 family members were recorded as having had leukaemia, two with CLL, one with CML and one with a type of AML referred to in 1940s as eosinophilic leukaemia. In addition, seven family members had been diagnosed with different solid tumours -uterine, stomach, rectal, abdomen, liver or oesophageal cancers and a breast sarcoma.
Through reference to the Danish archives, we sought verification of the cancer diagnoses in the individuals detailed in the 1947 pedigree and information on all the descendants of the original family members. Figure 2 shows the extended family that now comprises 222 family members. Verification of the original CLL cases was possible but the diagnoses for the CML or eosinophilic leukaemia cases in the original pedigree Table 1 summarizes the details of all of the family members affected by leukaemia in the extended kindred. The observation of 11 cases of malignant lymphoproliferative disorders (two cases of CLL from Videbaek's investigation, eight additional cases of CLL and one case of T-cell lymphoma from the follow-up) among the 222 members of the family represents a significant over-representation even accounting for the size of the family. Formal assessment of this by comparing the observed incidence of lymphoproliferative disorders in the family to that expected for the years covered by The Danish Cancer Registry (1943 to end of 2002) showed an eight-fold over-representation (eight observed, 1.01 expected, SIR ¼ 7.9; 95% CI: 3.4-15.6; Po0.0001). This overoccurrence is not due to biased ascertainment (preferential attention to multicase kindreds), for, while Videbaek's 'old' (pre-1943) case series might be beset with such a bias, the eight 'new' cases analysed here were prospectively ascertained through a virtually complete national register.
A total of the 17 members of the pedigree were documented to have been diagnosed with a nonhaematological cancer, two with nonmelanoma skin cancers, five women with breast carcinoma, and single cases of astrocytoma, gall bladder, gastric, colon, rectal, urinary bladder, ovarian, uterine and cervix cancers, and a case of unclassified metastasis (Figure 2 ). The frequency of breast cancer was elevated albeit only marginally significant (five observed, 1.94 expected, SIR ¼ 2.58; 95% CI: 0.84-6.0; two-sided P ¼ 0.09). Although these estimates of risk are in part naïve, as we have made no adjustment for familial relationships, 7 and hence confidence limits given may be too narrow, they serve to emphasize the over-representation of lymphoproliferative diseases and breast cancer in the family. The other nonhaematological cancers were not significantly different to those expected. Nor was total nonhaematological cancer remarkable (15 cases observed, 12.6 expected).
This family provides strong support for a familial predisposition to CLL and further vindicates the original hypothesis proposed by Videbaek in 1947. 2 While the mode of inheritance of CLL in this family is compatible with a dominant mode of inheritance, other models of inheritance cannot be excluded.
At present no genes which when mutated have unambiguously been shown to confer an increased risk of CLL. The overrepresentation of breast cancer in the family and the increased risk of this tumour in relatives of CLL cases observed in epidemiological studies 8, 9 raises the possibility that predisposition to CLL may involve disruption of genes encoding components of the BRAC1-BRAC2-ATM axis involved in the repair of DNA damage and fidelity of homlogous recombination. To date, there is, however, no evidence that germline mutations in either BRCA1 or BRCA2 confer an increased risk of CLL. 10, 11 For ATM, the data is perhaps more promising. Some epidemiological studies have shown significantly increased risks of both breast cancer and CLL in ATM heterozygotes 12, 13 and germline mutations in ATM have been reported in CLL patients. 14, 15 Additional candidates include other genes encoding components of the ATM pathway such as RAD52.
The identification of a susceptibility gene to CLL is likely to be dependent, at least in part, upon the analysis of CLL families either through genome-wide linkage searches or by direct assessment of candidate loci. The success of these approaches will inevitably depend critically upon establishing the necessary resource of CLL families. As well as providing insight into the nature of familial CLL, our 'revisiting' of Pedigree 14 shows that the careful follow up of previously published families provides a method of ascertaining large multigenerational families for genetic research.
